Cargando…

Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis

Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of choice. However, their use in the treatment of acute venous thromboembolism (VTE) in morbidly obese patients (bodyweight of > 120 kg or BMI > 40 kg/m(2)) guarded. This is due to the scarce data supporting thei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elshafei, Mohamed Nabil, Mohamed, Mouhand F. H., El-Bardissy, Ahmed, Ahmed, Mohamed Badie, Abdallah, Ibtihal, Elewa, Hazem, Danjuma, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886743/ https://www.ncbi.nlm.nih.gov/pubmed/32556939 http://dx.doi.org/10.1007/s11239-020-02179-4

Ejemplares similares

The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)

Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
por: Mohamed, Mouhand F. H., et al.
Publicado: (2021)

Colchicine use might be associated with lower mortality in COVID‐19 patients: A meta‐analysis
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2021)

The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review
por: Eljilany, Islam, et al.
Publicado: (2021)

The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis
por: Mohamed, Mouhand F. H., et al.
Publicado: (2021)

Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients: A protocol for systematic review and network meta-analysis using a generalized pairwise modeling methodology
por: Danjuma, Mohammed ibn-Mas’ud, et al.
Publicado: (2020)

Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature
por: Salem, Muhammad, et al.
Publicado: (2021)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
por: Eljilany, Islam, et al.
Publicado: (2021)

Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data
por: Alalawneh, Majdoleen, et al.
Publicado: (2023)

Preemptive Dose Adjustment Effect on the Quality of Anticoagulation Management in Warfarin Patients With Drug Interactions: A Retrospective Cohort Study
por: Fahmi, Amr Mohamed, et al.
Publicado: (2019)

Assessing Pharmacists Knowledge and Attitude Toward the Direct Oral Anticoagulants in Qatar
por: El-Bardissy, Ahmed, et al.
Publicado: (2020)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

An investigation into the impact of enteric coated of aspirin in patients with newly diagnosed ischemic stroke (ECASIS)
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study
por: Jun, Min, et al.
Publicado: (2017)

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism
por: Kang, Hye‐Rim, et al.
Publicado: (2023)

A Survey on the Awareness and Attitude of Physicians on Direct Oral Anticoagulants in Qatar
por: El-Bardissy, Ahmed, et al.
Publicado: (2018)

Economic Evaluation of Direct Oral Anticoagulants Compared to Warfarin for Venous Thromboembolism in Thailand: A Cost-Utility Analysis
por: Niyomsri, Siwaporn, et al.
Publicado: (2023)

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity
por: Cohen, Alexander, et al.
Publicado: (2021)

Cost-effectiveness Evaluations Among the Direct Oral Anticoagulants for the Prevention and Treatment of Venous Thromboembolism: Systematic Review
por: Al Mukdad, Mohammad, et al.
Publicado: (2019)

Evaluation of the Validity of SAMe-TT(2)R(2) Score in a Cohort of Venous Thromboembolism Patients Treated With Warfarin
por: Alhmoud, Eman Nawash, et al.
Publicado: (2020)

Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey
por: Eljilany, Islam, et al.
Publicado: (2020)

Efficacy and Safety of Direct Oral Anticoagulants in Venous Thromboembolism Compared to Traditional Anticoagulants in Morbidly Obese Patients: A Systematic Review and Meta-Analysis
por: Katel, Anjan, et al.
Publicado: (2021)

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
por: Lutsey, Pamela L., et al.
Publicado: (2019)

Clinical Outcomes of Direct Oral Anticoagulants vs Warfarin for Extended Treatment of Venous Thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2023)

The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2022)

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
por: Clay, Emilie, et al.
Publicado: (2018)

Osmolar-gap in the setting of metformin-associated lactic acidosis: Case report and a literature review highlighting an apparently unusual association
por: Elshafei, Mohamed Nabil, et al.
Publicado: (2020)

Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review
por: Fahmi, Amr Mohamed, et al.
Publicado: (2022)

Therapeutic options for the treatment of venous thromboembolism in case of warfarin intolerance: Effects of novel oral anticoagulants
por: Kodani, Eitaro
Publicado: (2013)

Recurrent Venous Thromboembolism in a Patient with Klippel-Trenaunay Syndrome Despite Adequate Anticoagulation with Warfarin
por: Asnake, Zekarias T, et al.
Publicado: (2020)

Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study
por: Khan, Adeel M., et al.
Publicado: (2022)

Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report
por: Fahmi, Amr Mohamed, et al.
Publicado: (2016)

Patient satisfaction after conversion from warfarin to direct oral anticoagulants for patients on extended duration of anticoagulation for venous thromboembolism – The SWAN Study
por: Hendriks, Thomas, et al.
Publicado: (2020)

Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort study
por: Scott, Lia C., et al.
Publicado: (2022)

The Use of Direct Oral Anticoagulants in the Management of Venous Thromboembolism in Patients With Obesity
por: Younis, Moustafa, et al.
Publicado: (2020)

Genomewide association analysis of warfarin dose requirements in Middle Eastern and North African populations
por: El Rouby, Nihal, et al.
Publicado: (2021)

Comparing the Efficacy and Safety of Apixaban Versus Warfarin in Morbidly Obese Patients
por: Alotaibi, Sultan N, et al.
Publicado: (2022)

Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin in Prevention of Thromboembolic Events Among Elderly Patients with Atrial Fibrillation
por: Kailas, Shilpa D, et al.
Publicado: (2016)

Comparative effectiveness and safety of extended anticoagulant therapy among Medicare beneficiaries with venous thromboembolism
por: Park, Haesuk, et al.
Publicado: (2022)

Effect of SAMe-TT(2)R(2) score and genetic polymorphism on the quality of anticoagulation control in Qatari patients treated with warfarin
por: Elewa, Hazem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l2u47r7pc3i0ejhfsbkro3cak4